SCHEMBL30264346

SCHEMBL30264346

C[Si](C)(C)CCOCn1c(Br)c(-c2cnc3ccccc3c2)c2c(N)ncnc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 0.46
SRC P12931 8/20 0.46
PIK3CD O00329 8/20 0.46
MTOR P42345 7/20 0.46
PRKDC P78527 7/20 0.46
PIK3CA P42336 6/20 0.46
PIK3CB P42338 6/20 0.46
PIK3CG P48736 6/20 0.46
KDR P35968 6/20 0.46
ABL1 P00519 5/20 0.46
HCK P08631 5/20 0.46
EPHB4 P54760 5/20 0.46
HDAC1 Q13547 2/20 0.41
BACE1 P56817 1/20 0.37
PI4KB Q9UBF8 1/20 0.37
FGFR2 P21802 3/20 0.36
PIK3C2B O00750 2/20 0.36
LCK P06239 1/20 0.36
TEK Q02763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30264739 0.83 EGFR (0.42) EGFRSRCPIK3CDMTORPRKDC
SCHEMBL20162797 0.81 CYP1A2 (0.40) EGFRSRCKDRABL1HCK
SCHEMBL30264709 0.80 SRC (0.48) EGFRSRCPIK3CDMTORPRKDC
SCHEMBL15487063 0.80 SRC (0.48) EGFRSRCPIK3CDMTORPRKDC
SCHEMBL30264648 0.79 EGFR (0.38) EGFRSRCPIK3CDMTORPRKDC
SCHEMBL26105112 0.78 NPC1 (0.36) EGFRKDRLCKTEK
SCHEMBL15220890 0.77 EGFR (0.46) EGFRSRCPIK3CDMTORPRKDC
SCHEMBL30264595 0.77 EGFR (0.40) EGFRSRCPIK3CDMTORPRKDC
SCHEMBL15221069 0.76 EGFR (0.47) EGFRSRCPIK3CDMTORPRKDC
SCHEMBL19562034 0.76 EGFR (0.47) EGFRSRCPIK3CDMTORPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392423-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE Arthrosi Therapeutics, Inc. (US) 2024-07-03 EP disclosed
WO-2023028054-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE ARTHROSI THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed